Ethical perspective on malaria research for Africa

Acta Tropica

Volumn 95, Issue 3, 2005, Pages 276-284

  Kilama, W L ^a  

^a African Malaria Network Trust   (Tanzania)

Author keywords

Antimalaria tools; Malaria vaccines

Indexed keywords

ANTIMALARIAL AGENT; DNA VACCINE; MALARIA VACCINE; ORAL POLIOMYELITIS VACCINE; VACCINIA VACCINE;

ACADEMIC RESEARCH; DISEASE CONTROL; EPIDEMIOLOGY; ETHICS; MALARIA;

AFRICA; AGE DISTRIBUTION; ARTICLE; CAUSE OF DEATH; CHILD HEALTH; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG RESEARCH; DRUG SAFETY; EMERGENCY TREATMENT; EPIDEMIC MENINGITIS; EPIDEMIOLOGICAL DATA; ETHNOPHARMACOLOGY; FINANCIAL MANAGEMENT; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HUMAN; INFECTION PREVENTION; INFORMED CONSENT; INSECTICIDE RESISTANCE; MALARIA; MEDICAL ETHICS; MEDICAL RESEARCH; MORTALITY; MOSQUITO; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POLIOMYELITIS; POPULATION RISK; PRACTICE GUIDELINE; RURAL HEALTH CARE; RURAL POPULATION; STANDARD; TREATMENT OUTCOME; TROPICS; VACCINATION; VACCINIA; VECTOR CONTROL; VIRUS INFECTION;

ADULT; AFRICA; CHILD, PRESCHOOL; CLINICAL TRIALS; DELIVERY OF HEALTH CARE; ETHICS, RESEARCH; FEMALE; HUMANS; INFANT, NEWBORN; MALARIA; MALARIA VACCINES; MOSQUITO CONTROL; PREGNANCY; RURAL HEALTH;

AFRICA; EASTERN HEMISPHERE; WORLD;

EID: 23944512125     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2005.06.011     Document Type: Article

References (23)

1. Barnes Lancet 363 2004 1598 http://www.scidev.net/
2. Bartlett, E.E., 2005. Draft, International Compilation of Human Subjects Protections, May 3.
3. Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO): International Guidelines for ethical Review of Epidemiological Studies. WHO, Geneva, 1991.
4. Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO): International Ethical Guidelines for Biomedical Research Involving Human Subjects, Geneva, 1993.
5. Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO): International Ethical Guidelines for Biomedical Research Involving Human Subjects, as last revised in Sep 2002; http://www.cioms.ch/frame_guidelines_nov_2002.htm
6. European Group on Ethics in Science and New Technologies (EGE), 2003. Opinion Nr 17 on the Ethical Aspects of Clinical Research in Developing Countries, published in Jan 2003; http://www.nuffieldbioethics.org/ developingcountries.
7. European Council and European Parliament (EU): Directive 2001/20/EC of the European Parliament and the Council on the Approximation of the Laws, Regulations and Administrative Provisions of the Member States Relating to Implementation of Good Clinical Practice in the Conduct of Clinical Trials on Medical Products for Human Use, April 2001. Adopted by members States by May 2003, brought into force May 2004; http://www.europa.eu.int/eur-lex/pri/en/oj/ dat/2001/l_121/l_12120010501en00340044.pdf.
8. Greenwood, Brian, Peter Smith, Geoff Target (WHO/IVR), 2004. Ethical considerations arising from vaccine trials conducted in pediatric populations with high disease burden in developing countries.
9. R.L. Koutzetsov Malaria control by application of indoor spraying of residual insecticides in tropical Africa and its implications on community health Trop Doctor 1977 81 91
10. James Lavery, and R. Nwabueze Showing respect for the dead: fair compensation for research autopsies in Malawi James V. Lavery Elizabeth Wahl Christine Grady Ezekiel J. Emanuel Case Studies in International Research Ethics 2004 Oxford University Press New York
11. Darryl Macer Ethical, Legal and Social Issues of Genetically Modified Disease Vectors in Public Health 2002 WHO/TDR Geneva
12. R. Macklin Double Standards in Medical Research in Developing Countries 2004 Cambridge University Press Nuffield Council of Bioethics 1999
13. National Bioethics Advisory Commission (NCBO), 2002. Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries http://www.bioethics.georgetown.edu/human/overvol1/html.
14. Nuffield Council on Bioethics, 2005. The Ethics of Research Related to Healthcare in Developing Countries, A Follow-up Discussion Paper. http://www.nuffieldbioethics.org.
15. J.B. Rugemalila W.L. Kilama Proceedings, Seminar on Health Research Ethics in Africa Acta Tropica 78 Supp. 1 2001 126 http://www.parasitology- online.com/
16. Schlatter, Catherine, 2005. Nigeria polio strain in Indonesia: Molecular Epidemiology Reveals Path Virus took from Africa to Asia. The Scientist, May 2005. http://www.news.surfwax.com/health/files/poliomyelitis.htm.
17. Steering Committee on Bioethics (CDBI) of the Council of Europe (CoE): Additional Protocol to the Convention on Human Rights and Biomedicine, Concerning Biomedical Research, Adopted by the Committee of Ministers, June 2004; http://www.conventions.coe.int/Treaty/EN/Projects/Protocol-biomedical. research.htm.
18. Stephens, Joe, 2000. As Drug Testing Spreads, Profits and Lives Hang in the Balance. http://www.washingtonpost.com/ac2/wp-dyn/A11939-2000 Dec15?language=printer.
19. Swiss Commission for Research Partnership with Developing Countries, 2002. Guidelines for Research in Partnership with Developing Countries, 2nd ed., pp. 56.
20. Yeya T. Toure, and Ayoade M.J.J. Oduola Biosafety and risk assessment in the use of genetically modified mosquitoes for disease control W. Takken T.W. Scott R.J. Bogers Proceedings of the Frontis workshop on ecological challenges concerning the use of genetically modified mosquitoes for disease control 2002 Kluwer Academic Publishers 217 222
21. C. Weiger, and R.A. Crouch Why should we include women and minorities in randomized and controlled trials? J Clin Ethics 10 1999 100 106
22. WHO/IRV, 2005. Ethical considerations arising from vaccine trials conducted in paediatric populations with high disease burden in developing countries. WHO/V&B/04.04, WHO, Geneva, pp. 49.
23. World Medical Association (WMA), 2000. Declaration of Helsinki as last revised in Oct 2000; Notes of Clarification on Paragraphs 29 and Paragraph 30 added 2002 and 2004: http://www.wma.net/e/approvedhelsinki.html.